Effectivity and safety profile of tenapanor, a sodium-hydrogen exchanger isoform 3 inhibitor, as an innovative treatment for hyperphosphatemia in chronic kidney disease: A systematic review of clinical studies William Suciangto, Haerani Rasyid, Anastasya Angelica Vicente, Winny Suciangto

Role of pyrophosphate in vascular calcification in chronic kidney disease Daniel Azpiazu, Sergio Gonzalo, Emilio González-Parra, Jesús Egido, Ricardo Villa-Bellosta

Colistimethate sodium and acute kidney injury: Incidence, risk factors, outcome and prognosis of renal function Saúl Pampa-Saico, Vicente Pintado, Alfonso Muriel, Fernando Caravaca-Fontan, Estefanía Yerovi-León, Aurora Rojo-Sanchis, José M. del Rey, M. Teresa Tenorio, Fernando Liaño